| 000 | 01251 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250511180224.0 | ||
| 264 | 0 | _c19920821 | |
| 008 | 199208s 0 0 eng d | ||
| 022 | _a0264-6021 | ||
| 024 | 7 |
_a10.1042/bj2850041 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGbenle, G O | |
| 245 | 0 | 0 |
_aPurification and properties of 3'-nucleotidase of Leishmania donovani. _h[electronic resource] |
| 260 |
_bThe Biochemical journal _cJul 1992 |
||
| 300 |
_a41-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenine Nucleotides _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCations, Divalent |
| 650 | 0 | 4 | _aChromatography, Liquid |
| 650 | 0 | 4 |
_aDithiothreitol _xpharmacology |
| 650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aIsoelectric Focusing |
| 650 | 0 | 4 |
_aLeishmania donovani _xenzymology |
| 650 | 0 | 4 |
_aNucleotidases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aZinc _xpharmacology |
| 700 | 1 | _aDwyer, D M | |
| 773 | 0 |
_tThe Biochemical journal _gvol. 285 ( Pt 1) _gp. 41-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1042/bj2850041 _zAvailable from publisher's website |
| 999 |
_c1328650 _d1328650 |
||